**----- Start of picture text -----**
The Head and Neck Cancer Research Trust No (if any)
1180082
Receipts and payments accounts CC16a
For the period Period start date Period end date
To
from 01/04/2023 31/03/2024
Section A Receipts and payments
Unrestricted Restricted Endowment
Total funds Last year
funds funds funds
to the nearest £ to the nearest £ to the nearest £ to the nearest £ to the nearest £
A1 Receipts
Donations 23,032 - - 23,032 -
- - - - -
- - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
Sub total (Gross income for
AR) [ 23,032 ] - - 23,032 -
A2 Asset and investment sales,
(see table).
- - - -
- - - - -
Sub total - - - - -
Total receipts 23,032 - - 23,032 -
A3 Payments
Computer costs 1,025 - - 1,025 20
Conference expenses 508 - - 508 892
Insurance 96 - - 96 96
Research costs 4,000 - - 4,000 -
Sponsorship costs 786 - - 786 -
Advertising costs 200 - - 200 -
Accountancy fees 300 - - 300 -
Other expenses 11 - - 11 -
Sub total [ 6,926 ] - - 6,926 1,008
A4 Asset and investment
purchases, (see table)
- - - -
- - - -
Sub total [ - ] - - - -
Total payments 6,926 - - 6,926 1,008
Net of receipts/(payments) 16,106 - - 16,106 - 1,008
A5 Transfers between funds - - - - -
A6 Cash funds last year end 1,259 - - 1,259 2,267
Cash funds this year end 17,365 - - 17,365 1,259
**----- End of picture text -----**
CCXX R1 accounts (SS) 30/01/2025 1 ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B1 Cash funds**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B5 Liabilities**
**B3 Investment assets**|Signature
**Details**
**Details**
NatWest bank account
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**17,365**
**-**
**-**
**-**
**-**
**-**
**17,365**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
A Mertens|**Endowment**
**funds**
**to nearest £**
**-**
**-**
**-**| |---|---|---|---| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**Current value**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**Current value**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**When due**
**(optional)**
Date of
approval| CCXX R2 accounts (SS) 30/01/2025 2